Follow the Aardvark Therapeutics, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €159.8m. The latest transaction was filed on 12 December 2025 (Acquisition). Among the most active insiders: Lee Tien-Li. Every trade is accessible without an account.
15
Insider Decl.
n/a
Thresholds
€307,948
6 ops.
Buy Volume
n/a
n/a
Sell Volume
47Σ signal
Buys €307,948n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Aardvark Therapeutics, Inc. es una empresa centrada en el desarrollo de tratamientos innovadores para enfermedades específicas. Cotiza en el mercado XNAS.